Matthew Roberts, Ph.D. MBA is the Chief Technology Officer at the H&H Group, Hong Kong. Dr. Roberts formerly acted as the Chief Scientific Officer and Senior Vice President of Innovation for ChromaDex. ChromaDex’s flagship product is TRU NIAGEN®, the only known patented and FDA notified [Generally Recognized as Safe or GRAS] form of nicotinamide riboside (NR) on the market today.
Dr. Roberts received his Ph.D. in Environmental and Comparative Toxicology from Cornell University, his M.B.A. from the Olin School of Business at Washington University, and his B.S. in Plant Molecular Biology and Physiology from Purdue University.
He is an accomplished innovation executive with over 25 years of success at Abbott, Nestle, The Nature’s Bounty Company, and Pharmavite. Dr. Roberts is focused on driving growth-phase market opportunities across the food, nutrition, and agricultural sectors. He learns by doing, which means that in addition to managing he enjoys riding with the sales force, working a shift in the factory or field, and participating in the laboratory whenever possible.
He has achieved outstanding results, in commercial and research functions, leading to the successful introduction of new food products, ingredients, science, and technology which then delivered real business results in the marketplace.
His acquisitions have resulted in significant structural shifts in the human and companion animal nutrition industry. He also has significant experience in corporate innovation strategy, stage-gate processes, and corporate partnerships.